XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1

Revenues (Tables)

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2017 and 2016:

	Three months ended June 30,								Six months ended June 30,
	2017				2016				2017				2016
Products:
Acetadote	$	1,723,984			$	1,895,199			$	2,989,424			$	3,732,661
Omeclamox-Pak	377,470				641,469				1,022,795				1,401,788
Kristalose	2,901,440				3,626,076				5,288,031				7,243,882
Vaprisol	276,705				421,800				961,253				789,848
Caldolor	1,052,917				631,893				1,865,944				1,703,861
Ethyol	2,091,836				—				5,758,644				—
Other	242,775				198,398				417,791				280,327
Total net revenues	$	8,667,127			$	7,414,835			$	18,303,882			$	15,152,367

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration